TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - ABBOTT LABORATORIES Stock

Certificat

DE000SW1FZ12

Market Closed - Deutsche Boerse AG 03:40:11 2024-07-11 pm EDT
4.16 EUR -3.70% Intraday chart for TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - ABBOTT LABORATORIES
Current month+1.41%
1 month+12.21%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-11 4.16 -3.70%
24-07-10 4.32 -2.48%
24-07-09 4.43 +1.61%
24-07-08 4.36 +3.32%
24-07-05 4.22 -2.09%

Delayed Quote Deutsche Boerse AG

Last update July 11, 2024 at 03:40 pm EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Société Générale Société Générale
WKN SW1FZ1
ISINDE000SW1FZ12
Date issued 2023-07-25
Strike 149.2 $
Maturity Unlimited
Parity 10 : 1
Emission price 3.24
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5.64
Lowest since issue 2.56

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
103 USD
Average target price
124.8 USD
Spread / Average Target
+21.08%
Consensus